Your session is about to expire
← Back to Search
Methadone for Cancer Pain (METHADOPT Trial)
METHADOPT Trial Summary
This trial will compare the effectiveness of methadone to morphine in treating a specific type of cancer pain.
- Cancer Pain
- Adenocarcinoma
METHADOPT Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowMETHADOPT Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.METHADOPT Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is this clinical trial open to patients who are not yet 50 years old?
"The age restrictions for participants in this trial are that they must be over 18 years old but under 75 years old."
Are there currently any open positions in this clinical trial?
"According to clinicaltrials.gov, this trial is not presently looking for patients. This study was originally posted on June 1st, 2022 and was last updated on April 13th, 2022. Although this trial is not currently recruiting, there are 814 other trials that are."
Are there any specific eligibility requirements for this clinical trial?
"This clinical trial is looking for 40 participants aged 18 to 75 who are currently experiencing cancer pain. In addition to cancer pain, the following inclusion criteria must be met: Cancer type is adenocarcinoma;, Eastern Cooperative Oncology Group Performance Status (ECOG PS) of 0 to 2;, Estimated prognosis of at least 3 months;, Able to fill out questionnaires and understand procedures in English and/or French;, Able to provide first person informed consent;, Physician deems it appropriate to start the patient on the opioid., In the physician's opinion, mechanism of pain is most likely linked to"
Share this study with friends
Copy Link
Messenger